GHOSH ANIRVAN (Chief Executive Officer) sold 1.2% of their position (1.02K shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/1/2023ACC: 0000950170-23-036454
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-1.02K
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.02K disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−1.02K
Price / share
$2.86
Trade value
$2.92K
% of position
1.2%
7/31/2023
85.07K→84.05K
Total
Net shares
−1.02K
Net value
-$2.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 7/31/2023 | S · Sale | −1.02K | $2.86 | $2.92K | 1.2% | 85.07K | 84.05K |
| Total | −1.02K | -$2.92K | ||||||
Derivative Transactions0
No derivative transactions reported